Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.

作者: Jordi Bruna , Laura González , Júlia Miró , Roser Velasco , Miguel Gil

DOI: 10.1002/CNCR.24041

关键词:

摘要: BACKGROUND Leptomeningeal carcinomatosis (LC) represents a devastating complication of systemic cancer, and patients with LC have dismal prognosis increased mortality. The few studies that focused on the evaluation prognostic factors in resulted contradictory results. Thus, treatment remains controversial, no straightforward guidelines exist literature. objective current study was to identify markers related survival better select who are eligible for intensive treatment. METHODS Seventy had diagnosis were reviewed, clinical data, cerebrospinal fluid (CSF) parameters, tumor-related characteristics, information registered. impact single parameters overall determined by both univariate multivariate analyses. RESULTS analysis revealed Radiation Therapy Oncology Group score or=2.7 mmol/L (P=.001), presence infratentorial symptoms at onset (P=.026), intrathecal (P<.001) associated independently longer LC. In addition, same also predicted response such patients. CONCLUSIONS predictive identified this could help more likely benefit from chemotherapy.

参考文章(31)
Jordi Bruna, Íñigo Rojas-Marcos, Sergio Martínez-Yelamos, Isabel Català, Antonio Vidaller, Carmen Galán, Jurek Krupinski, Francisco Rubio, None, Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder. Journal of Neuro-oncology. ,vol. 63, pp. 63- 67 ,(2003) , 10.1023/A:1023781604980
Lisa M. DeAngelis, Current diagnosis and treatment of leptomeningeal metastasis Journal of Neuro-oncology. ,vol. 38, pp. 245- 252 ,(1998) , 10.1023/A:1005956925637
J. Hildebrand, Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthood. Journal of Neuro-oncology. ,vol. 38, pp. 193- 198 ,(1998) , 10.1023/A:1005976003347
C C Schag, R L Heinrich, P A Ganz, Karnofsky performance status revisited: reliability, validity, and guidelines. Journal of Clinical Oncology. ,vol. 2, pp. 187- 193 ,(1984) , 10.1200/JCO.1984.2.3.187
Bernard F. Cole, Bruce S. Chozick, Catherine M. Shannon, Lars Wahlberg, Wallace Akerley, Lorraine Marin, Hak Choy, Michael J. Glantz, Walter A. Hall, Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid‐flow status Cancer. ,vol. 75, pp. 2919- 2931 ,(1995) , 10.1002/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9
Audrey M. Sherman, Kurt Jaeckle, Christina A. Meyers, Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease Cancer. ,vol. 95, pp. 1311- 1316 ,(2002) , 10.1002/CNCR.10816
Bruce Borgelt, Richard Gelber, Simon Kramer, Luther W. Brady, Chu H. Chang, Lawrence W. Davis, Carlos A. Perez, Frank R. Hendrickson, The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group International Journal of Radiation Oncology Biology Physics. ,vol. 6, pp. 1- 9 ,(1980) , 10.1016/0360-3016(80)90195-9
Gerald Clamon, Bradley Doebbeling, Meningeal carcinomatosis from breast cancer: Spinal cord vs. brain involvement Breast Cancer Research and Treatment. ,vol. 9, pp. 213- 217 ,(1987) , 10.1007/BF01806382